Recent advances in paediatric dermatology

Kate Khorsand1, Robert Sidbury2

  • 1University of Washington School of Medicine, Seattle, Washington, USA.

Insights

This review summarizes recent clinical guidelines and research in pediatric dermatology. It focuses on common diagnoses and treatments, including rheumatologic overlap, psoriasis, and pigmented lesions, for practicing pediatricians.

Area of Science:

  • Pediatric Dermatology
  • Clinical Guidelines
  • Rheumatologic Overlap Disorders

Background:

  • Recent advancements in pediatric dermatology have been significant.
  • New clinical guidelines have been published in the past year.
  • Research has expanded on rheumatologic overlap disorders, psoriasis comorbidities, and pigmented lesions.

Purpose of the Study:

  • To review common diagnoses and treatments in pediatric dermatology.
  • To highlight recent clinical guidelines relevant to pediatricians.
  • To summarize important research on specific dermatologic conditions and their impact.

Main Methods:

  • Literature review of recent publications and guidelines.
  • Synthesis of information on common pediatric dermatologic conditions.
  • Focus on practical information for practicing pediatricians.

Main Results:

  • Several new clinical guidelines pertinent to pediatric dermatology are now available.
  • Important research has been conducted on rheumatologic overlap disorders.
  • Psoriasis comorbidities and the quality of life impact of skin conditions have been further elucidated.

Conclusions:

  • Practicing pediatricians can benefit from this review of common pediatric dermatology diagnoses and treatments.
  • The review provides an update on key areas including rheumatologic overlap, psoriasis, and pigmented lesions.
  • Understanding recent guidelines and research improves patient care in pediatric dermatology.

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
94